AC
SLDB icon

AXQ Capital’s Solid Biosciences SLDB Stock Holding History

AXQ Capital’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$197K Buy
+19,739
New +$150K 0.02% 729
2026
Q1 		– Sell
-20,647
Closed -$116K – 1238
2025
Q4 		$116K Sell
20,647
-3,388
-14% -$18.4K 0.03% 636
2025
Q3 		$148K Buy
+24,035
New +$141K 0.06% 482

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AXQ Capital's SLDB Position: Q2 2026 in Review

AXQ Capital opened a new position in Solid Biosciences (SLDB) in Q2 2026: 19,739 shares worth $197K. The stake represents 0.02% of the portfolio and ranks #729 among its holdings. This is a return to the name: AXQ Capital previously reported a position in SLDB as recently as Q4 2025.

AXQ Capital first reported a position in SLDB in Q3 2025 and has held it in 3 quarters since. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • AXQ Capital held 19,739 shares of Solid Biosciences worth $197K as of Q2 2026.
  • Solid Biosciences was a new AXQ Capital position in Q2 2026.
  • Solid Biosciences made up 0.02% of AXQ Capital's portfolio in Q2 2026, its #729 holding.
  • AXQ Capital first reported a position in Solid Biosciences in Q3 2025 and has held it in 3 quarters since.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.